Fermin Ruiz de Erenchun

WORK HISTORY

EDUCATION

SKILLS

ABOUT FERMIN RUIZ DE ERENCHUN

Key value proposition• 30 years on leadership roles in the healthcare industry (large pharma, biotech start up and diagnostics)• In depth understanding and experience across multiple functions and therapeutic areas of the pharma and diagnostics value chain • Knowledge and understanding of small biotech start up challenges transitioning from an academic culture and set up, to implementing business operations compliant with GxP• Experience in raising funds for biotech start up, participating with the CEO in partnering conferences, presentations to large institutional investors, private investors, banks, family offices and pharmaceutical companies, and in raising non-diluting funds.• Solid scientific and technical background • Innovative and driven to mobilize people and organizations; career driven by taking new challenges, innovative projects, building new teams and delivering resultsSummary of Professional Career • Clinical development and medical affairs: Implemented phase I to IV clinical trials in multiple therapeutic areas (oncology, rheumatoid arthritis, transplantation, virology, cardiology). Developed and implemented regional and global medical affairs strategic plans for the launch of several products in oncology and inflammation/auto-immune disorders, including large phase IV and safety studies. • Global product strategy and product life cycle management: led global multi-functional teams during the global development, registration and launch of a major oncology brand in different indications, including two approval by European Commission. Development of global strategic franchise plan, and the lung cancer disease area strategic plan. Led the development and implementation of the corporate strategy to address the entry of biosimilars of the three major oncology brands. Presentations to investors and analysts at multiple forums, including the pharma investor day (2015)• General management in an emerging market (Peru)• Governmental affairs and public policy:• Global business development - Roche Diagnostics • Chief Operating Officer: overseeing the day-to-day operations of the company and ensuring that the company is executing its strategic plan, and developing and implementing processes to ensure regulatory compliance.• Chief Medical Officer: development of the Clinical Development plan, the First in Human protocol (phase I) and the biomarker strategy for the lead asset of a biotech start up company in oncology (basket trial in multiple tumour types). Lead regulatory interactions with regulatory authorities in the UK (MHRA).